Key facts
- This page summarizes Olav Bergheim's Form 4 filing for Adagio Medical Holdings, Inc. (ADGM).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 02 Aug 2024, 08:00.
Olav Bergheim - 31 Jul 2024 Form 4 Insider Report for Adagio Medical Holdings, Inc. (ADGM)
- Reporting relationship
- CEO, Director
- Issuer ticker
- ADGM
- Reported as of
- 31 Jul 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Aug 2024, 08:00:12 UTC
- Prior SEC filing
- 17 May 2024
- Next SEC filing
- 19 Sep 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Dahldorf, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Olav Bergheim filed Form 4 for Adagio Medical Holdings, Inc. (ADGM) on 02 Aug 2024.
Change
- Previous filing in this sequence was filed on 17 May 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ADGM
transaction
Common Stock
Other
- Transaction value
- Shares
- +212,053
- Change %
- Price
- Shares after
- 212,053
- Date
- 31 Jul 2024
- Ownership
- By Fjordinvest LLC
- Footnotes
- F1, F2
ADGM
transaction
Common Stock
Other
- Transaction value
- Shares
- +22,081
- Change %
- Price
- Shares after
- 22,081
- Date
- 31 Jul 2024
- Ownership
- By Micro NV LLC
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Pursuant to the business combination (the "Business Combination") contemplated by the Business Combination Agreement, dated February 13, 2024, as amended, by and among Adagio Medical Holdings, Inc. (formerly known as Aja Holdco Inc., "New Adagio" and following the completion of the Business Combination, the "Issuer"), ARYA Sciences Acquisition Corp IV, Adagio Medical, Inc. ("Adagio") and certain other parties thereto, as described in the Registration Statement on Form S-4 (File No. 333-278811) filed with the U.S. Securities0 and Exchange Commission and declared effective on July 12, 2024, acquired by the reporting person in exchange for the shares of Adagio common stock held indirectly by the reporting person prior to the completion of the Business Combination.
Footnote F2
Shares held by Fjordinvest LLC. The reporting person is the President of Fjordinvest LLC and, as such, has voting and investment discretion over the shares held by Fjordinvest LLC.
Footnote F3
Shares held by Micro NV LLC. The reporting person is the President of Micro NV LLC and, as such, has voting and investment discretion over the shares held by Micro NV LLC.